Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Mouse study offers promise for MS
“Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases."

Scientists explore personalised treatments based on skin cells 

New research on mice suggests that personalised stem cell treatment could offer relief from progressive multiple sclerosis (MS).

Led by the University of Cambridge, researchers re-programmed skin cells into brain stem cells and transplanted them into the central nervous system. Findings published in the journal Cell Stem Cell suggest this reduced inflammation and may even help to repair the damage caused by MS.

In patients with MS, the body’s own immune system attacks and damages the protective myelin sheath around nerve fibres. This causes disruptions to messages sent around the brain and spinal cord. Symptoms are unpredictable and include mobility and balance problems, pain and severe fatigue.

Previous research at Cambridge has shown that transplanting neural stem cells (NSCs) - which are part-way to developing into nerve cells - reduces inflammation and can help the CNS to heal.

However, NSCs cannot be obtained in large enough quantities as they are sourced from embryos. There is also a risk that the body will see view them as an alien invader and trigger an immune response to destroy them.

Researchers say a possible solution is using ‘induced neural stem cells’ which can be created by taking a patient’s skin cells and re-programming them to become NSCs. As these iNSCs would be the patient’s own, scientists say they are less likely to trigger an immune response.

In their study, the team used mice that had been manipulated to develop MS. They found that chronic MS leads to significantly higher levels of succinate in cerebrospinal fluid. Succinate is a small metabolite that ‘tricks’ macrophages and microglia into causing inflammation.

Transplanting NSCs and iNSCs into the cerebrospinal fluid reduces the amount of succinate, they said - effectively turning ‘bad’ immune cells ‘good’. As a result, there is a decrease in inflammation and secondary damage to the brain and spinal cord.

Lead author Dr Stefano Pluchino explained: “Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS.

“This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of an adverse immune response.”

Become a member or log in to add this story to your CPD history

Report: A third of Welsh birds are in decline

News Story 1
 A report by RSPB Cymru and partnering ornithology organisations has revealed that a third of bird species in Wales are in significant decline.

90 per cent of Wales is farmed and there is now pressure to implement new land management policies that will aid in nature restoration.

Patrick Lindley, Maritime Ornithologist for Natural Resources Wales, commented: “The problems that confront UK birds, whether they are breeding or non-breeding, are pressure and threats that confront entire ecosystems.

“Birds are a great indicator to the health of our environment. The continued population declines of birds of farmed, woodland and upland habitats suggest there are large geographic themes that are having a detrimental impact.”  

Click here for more...
News Shorts
BSAVA announces winner of 2019 Bourgelat Award

One of the world’s leading small animal medicine specialists is set to receive the prestigious Bourgelat Award at BSAVA Congress 2019.

Professor Mike Herrtage will be recognised for his major research into metabolic and endocrine diseases, including diabetes mellitus, Cushing’s disease and Addison’s disease.

During his career, Prof Herrtage has co-authored more than 100 scientific papers and written more than 200 other publications such as abstracts, books and chapters. He also continues to be a source of inspiration for thousands of undergraduate and postgraduate veterinary surgeons.